Neonatal Serum Phosphorus Levels and Enamel Defects in Very Low Birth Weight Infants

Roula Merheb1, Chitra Arumugam2, Wonik Lee3

  • 1Department of Pediatrics, Division of Neonatology, MetroHealth Medical Center and Case Western Reserve University, Cleveland, Ohio, USA rmerheb@metrohealth.org.

Insights

Very low birth weight (VLBW) infants with lower serum phosphorus levels are more likely to develop enamel hypoplasia. This finding highlights the importance of monitoring phosphorus in VLBW infants for dental health.

Area of Science:

  • Neonatalogy
  • Pediatric Dentistry
  • Nutritional Science

Background:

  • Very low birth weight (VLBW) infants face increased risks of enamel defects due to missing critical in-utero mineral accretion.
  • Limited research exists on the link between neonatal nutrition and dental outcomes in preterm, VLBW infants.

Purpose of the Study:

  • To investigate the relationship between neonatal nutrition biomarkers, feeding intake, comorbidities, and enamel defects in VLBW infants.

Main Methods:

  • Retrospective chart review of 76 VLBW infants (2007-2010).
  • Infants classified as cases (enamel defects) or controls (no enamel defects) at 8, 18-20, and 36 months.
  • Demographic, medical, and nutritional data were collected.

Main Results:

  • 62% of VLBW infants exhibited enamel defects (hypoplasia/opacity).
  • Lower serum phosphorus levels were significantly associated with enamel hypoplasia.
  • A 1-mg/dL increase in serum phosphorus reduced odds of enamel hypoplasia by 68% (OR, 0.322; P = .024).

Conclusions:

  • Neonatal hypophosphatemia is a significant risk factor for enamel hypoplasia in VLBW infants under three years old.
  • Monitoring serum phosphorus levels is crucial for preventing dental anomalies in this vulnerable population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
4.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Introduction to Electrolytes01:33

Introduction to Electrolytes

In humans, electrolytes play a vital role in various physiological processes. Balancing electrolyte levels is essential for normal body functions; their imbalance can be life-threatening. The major electrolytes include sodium, potassium, chloride, calcium, phosphate, and bicarbonate. They are primarily involved in physiological processes, such as nerve signal transmission, membrane trafficking, muscle contraction, buffering body fluids, and balancing water levels in the body.
Role of Sodium
One...
18.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391